Diabetic patients were treated intensively with insulin for 2 months to improve glycemic control and used GLP-1 infusion. In OGTT use of GLP-1 may protect endothelia function during hyperglycemia, reducing oxidative stress generation compared to placebo. The gene discussed is GLP1R; the disease is Hyperglycemia.